Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1195765-45-7
Purity
95%
Dabrafenib is an orally bioavailable inhibitor of B-raf protein with antineoplastic activity. It is used to treat patients with specific types of melanoma, non-small cell lung cancer, and thyroid cancer.
Properties
Name
Dabrafenib
Smiles
CC(C)(C)C1=NC(=C(S1)C=2C=CN=C(N)N2)C=3C=CC=C(NS(=O)(=O)C=4C(F)=CC=CC4F)C3F
Targets
Please log in to see this information
SDS
GSK2118436 | GSK2118436A | dabrafenib | tafinlar
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$45
2 mg
$47
5 mg
$48
10 mg
$49
15 mg
$50
20 mg
$51
25 mg
$55
30 mg
$59
35 mg
$67
40 mg
$74
45 mg
$81
50 mg
$88
75 mg
$94
100 mg
$96
Quantity
1
Total amount
$ 48
GSK2118436 | GSK2118436A | dabrafenib | tafinlar
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:1195768-06-9
0